Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Social Anxiety Disorder (SAD): full-pipeline trial registry
4 of 6 indexed Social Anxiety Disorder (SAD) trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Social Anxiety Disorder (SAD): 6 US clinical trials tracked, 4 recruiting.
Social Anxiety Disorder (SAD) is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Engrail Therapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition social-anxiety-disorder-sad
OPEN 4 | RECR 67% | LATE 3 | EARLY 2 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)
Social Anxiety Disorder (SAD) lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Social Anxiety Disorder (SAD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Social Anxiety Disorder (SAD) is recruiting above its size-band peers.
4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Social Anxiety Disorder (SAD) research.
Engrail Therapeutics accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Social Anxiety Disorder (SAD) enrolment sits around 106 participants.
Median target enrolment is 106 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.
-
Social Anxiety Disorder (SAD) research is mostly interventional.
6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder
Vanda Pharmaceuticals
NCT07221578
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
VistaGen Therapeutics
NCT06615557
Stepped Care Treatment for Anxiety Resilience
Andrew Wiese
NCT07228143
A Study of NTX-1472 in Social Anxiety Disorder
Newleos Therapeutics
NCT07323784
A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder
Engrail Therapeutics
NCT07193563
Nefazodone in the Treatment of Social Phobia
Emory University
NCT00231348
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Social Anxiety Disorder (SAD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Social Anxiety Disorder (SAD) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Social Anxiety Disorder (SAD) page
6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Social Anxiety Disorder (SAD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Engrail Therapeutics sponsors the most Social Anxiety Disorder (SAD) trials on record, review their full trial history before evaluating a specific study. See Engrail Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Social Anxiety Disorder (SAD) condition card totals 6 registered trials; most-linked intervention Placebo; top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.